Showing results (151-160 of 3,013) with videos related to
Sort By:
Pageof 302
Cardiovascular Drugs and Therapy|May 25, 2010
The second window of preconditioning (SWOP) where are we now?Derek J Hausenloy, Derek M YellonCardiovascular Drugs and Therapy|April 1, 1990
Felodipine prevents the poststenotic myocardial ischemia induced by alpha 2-adrenergic coronary constrictionT Ehring, G HeuschCardiovascular Drugs and Therapy|August 1, 1990
The initial hemodynamic response to newer antihypertensive agents at rest and during exercise: review of visacor, doxazosin, nisoldipine, tiapamil, perindoprilat, pinacidil, dilevalol, and carvedilolP Omvik, P Lund-JohansenCardiovascular Drugs and Therapy|August 1, 1990
Evolution of free radical formation during low-flow ischemia and reperfusion in isolated rat heartV Maupoil, L Rochette, A Tabard, et al.Cardiovascular Drugs and Therapy|June 1, 1990
Effect of OPC-8490 on the membrane potentials and membrane currents of single guinea-pig myocytesY Momose, S SasayamaCardiovascular Drugs and Therapy|September 19, 2009
Endothelial cell seeding fails to prevent intimal hyperplasia following arterial injury in the rat carotid modelBertram J Jobst, Guenter A J Riegger, Daniel P GrieseCardiovascular Drugs and Therapy|July 4, 1998
Calcium channel blockers and the risk of cancer: a preclinical assessmentH J Ahr, E Bomhard, H Enzmann, et al.Cardiovascular Drugs and Therapy|July 4, 1998
Safety, tolerability, and neurohormonal changes of the combination captopril plus losartan in the early postinfarction period: a pilot studyP Di Pasquale, V Bucca, S Scalzo, et al.Cardiovascular Drugs and Therapy|May 13, 2020
Efficacy and Safety of Inorganic Nitrate Versus Placebo Treatment in Heart Failure with Preserved Ejection FractionYajun Gui, Jingyuan Chen, Jiahui Hu, et al.Cardiovascular Drugs and Therapy|May 13, 2020
Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling PathwayXing Chen, Xingzuan Jiang, Chuanfang Cheng, et al.Pageof 302